Join the Crypteck Hackathon | $5 million in prizes & seed funding | Jump in, the water's just fine ->

token sale

We provide the solution for asset management

shade_image

ABOUT TOKEN

Token Sale

ICO Crypto is a platform for the future of funding that powering dat for the new equity blockchain.

Cryptico token will be released on the basis of Ethereum and Bitocin platform. It’s compatibility of the token with third-party services wallets, exchanges etc, and provides easy-to-use integration.

$25,256,432 contribution received
$55m
$5M

Softcap in 1069 days

Hardcap

Buy tokens now

We accept

token distribution

Start

Jan 15, 2022 (9:00 AM GMT)

Number of tokens for sale

900,000 CRT (9%)

End

Feb 28, 2022 (12:00 AM GMT)

Tokens exchange rate

1 ETH= 670 CRT, 1 BTC= 2003 CRT

Acceptable currencies

ETH, BTC, NAT

Minimal transaction amount

1 ETH/ 1 BTC/ 1 NAT

token distribution
Token name:

Crypteck

Ticker Symbol:

CRT

Pre-ICO:
Feb 1, 2022 – Mar 2, 2022
Tokens to sell: 54,000,000 CRT
Token Sale:
Mar 25, 2022 – Apr 30, 2022
Tokens to sell: 300,000,000 CRT
Inital Price:

2500 CRT = 1 ETH

Currencies Accepted:

ETH, CTC, LTD, BCH, LTC

Hidden CAP:

Revealed if 70% of the cap is reached

Minimum Purchase:

0.1 CRT

Allocation of funds

Total token syply – 10,000,000,000 SDW

  • 10% Private Sale
  • 30% Burned
  • 20% Public Sale
  • 28% Staking Reward
  • 7% Partneship Fundsward
  • 5% Team Pool

Team tokens are locked for the first 6 months and will be vested over a period of 12 months total.

Tokens reserved to advisors will be locked for 1 month minimum.

token sale stages

state 1

30%

bonus

1 day only

Start in

02.28.2023 19:08:00

state 2

20%

bonus

1 day only

End in

08.31.2022 19:08:00

state 3

15%

bonus

2 weeks

Start in

02.28.2023 19:08:00

state 1

0%

bonus

1 month

Start in

02.28.2023 19:08:00

FAQs

Meet the dedicated team behind Crypteck. Together, they work tirelessly to

lay the foundation for a unique metavers.

Pretium mauris viverra eget nulla eu auctor scelerisque risus. Ornare morbi pulvinar ipsum gravida rutrum. Aliquam aliquet ac vitae pellentesque lectus elementum. Nunc mus et, pulvinar facilisi viverra. At amet mauris fermentum sed. Aliquam ut rhoncus et semper non purus massa risus. Tristique mattis in sed dictum cursus eu lorem placerat.

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
Haven’t got your answer?
Contact our support now